Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

Clinical trial NCT05329545 · TERMINATED

Trial details

NCT number: NCT05329545
Sponsor: Mersana Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

High Grade Serous Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2022-06-23
Primary completion: 2023-09-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.